Table of Content

1 Engineered T Cells Market Introduction and Overview
1.1 Engineered T Cells Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Engineered T Cells Revenue and Market Share by Manufacturer
2.2 Manufacturers Engineered T Cells Production Sites, Area Served, Product Types
2.3 Engineered T Cells Market Competitive Situation and Trends
2.3.1 Engineered T Cells Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2024
2.3.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 Autolus Limited
3.1.1 Autolus Limited Company Profile
3.1.2 Engineered T Cells Product Overview
3.1.3 Autolus Limited Engineered T Cells Market Performance (2019-2024)
3.1.4 Autolus Limited Business Overview
3.2 Bellicum Pharmaceuticals
3.2.1 Bellicum Pharmaceuticals Company Profile
3.2.2 Engineered T Cells Product Overview
3.2.3 Bellicum Pharmaceuticals Engineered T Cells Market Performance (2019-2024)
3.2.4 Bellicum Pharmaceuticals Business Overview
3.3 Cells Medica
3.3.1 Cells Medica Company Profile
3.3.2 Engineered T Cells Product Overview
3.3.3 Cells Medica Engineered T Cells Market Performance (2019-2024)
3.3.4 Cells Medica Business Overview
3.4 Elli Lilly and Company
3.4.1 Elli Lilly and Company Company Profile
3.4.2 Engineered T Cells Product Overview
3.4.3 Elli Lilly and Company Engineered T Cells Market Performance (2019-2024)
3.4.4 Elli Lilly and Company Business Overview
3.5 Gilead Sciences
3.5.1 Gilead Sciences Company Profile
3.5.2 Engineered T Cells Product Overview
3.5.3 Gilead Sciences Engineered T Cells Market Performance (2019-2024)
3.5.4 Gilead Sciences Business Overview
3.6 Juno Therapeutics
3.6.1 Juno Therapeutics Company Profile
3.6.2 Engineered T Cells Product Overview
3.6.3 Juno Therapeutics Engineered T Cells Market Performance (2019-2024)
3.6.4 Juno Therapeutics Business Overview
3.7 Novartis
3.7.1 Novartis Company Profile
3.7.2 Engineered T Cells Product Overview
3.7.3 Novartis Engineered T Cells Market Performance (2019-2024)
3.7.4 Novartis Business Overview
3.8 Oxford Biomedica
3.8.1 Oxford Biomedica Company Profile
3.8.2 Engineered T Cells Product Overview
3.8.3 Oxford Biomedica Engineered T Cells Market Performance (2019-2024)
3.8.4 Oxford Biomedica Business Overview
3.9 Pfizer
3.9.1 Pfizer Company Profile
3.9.2 Engineered T Cells Product Overview
3.9.3 Pfizer Engineered T Cells Market Performance (2019-2024)
3.9.4 Pfizer Business Overview
3.10 Precision Bioscience
3.10.1 Precision Bioscience Company Profile
3.10.2 Engineered T Cells Product Overview
3.10.3 Precision Bioscience Engineered T Cells Market Performance (2019-2024)
3.10.4 Precision Bioscience Business Overview
3.11 Redmile Group
3.11.1 Redmile Group Company Profile
3.11.2 Engineered T Cells Product Overview
3.11.3 Redmile Group Engineered T Cells Market Performance (2019-2024)
3.11.4 Redmile Group Business Overview
3.12 Seeking Alpha
3.12.1 Seeking Alpha Company Profile
3.12.2 Engineered T Cells Product Overview
3.12.3 Seeking Alpha Engineered T Cells Market Performance (2019-2024)
3.12.4 Seeking Alpha Business Overview
3.13 Unum Therapeutics
3.13.1 Unum Therapeutics Company Profile
3.13.2 Engineered T Cells Product Overview
3.13.3 Unum Therapeutics Engineered T Cells Market Performance (2019-2024)
3.13.4 Unum Therapeutics Business Overview
4 Global Engineered T Cells Historical and Forecast Market Analysis by Type
4.1 Global Engineered T Cells Revenue and Market Share by Type
4.2 Global Engineered T Cells Revenue Market Forecast by Type (2024-2030)
5 Global Engineered T Cells Historical and Forecast Market Analysis by Application
5.1 Global Engineered T Cells Revenue Market Share by Application (2019-2024)
5.2 Engineered T Cells Revenue Market Forecast by Application (2024-2030)
6 Global Market Growth Trends Analysis
6.1 Global Engineered T Cells Market Size & Forecast (2019-2030)
6.2 Engineered T Cells Growth Trends Analysis by Regions
6.2.1 Engineered T Cells Market Size by Regions: 2019 VS 2024 VS 2030
6.2.2 Engineered T Cells Historic Revenue Market Size by Regions (2019-2024)
6.2.3 Engineered T Cells Forecasted Revenue Market Size by Regions (2024-2030)
6.2.4 North America Engineered T Cells Market Size & Forecast (2019-2030)
6.2.5 Europe Engineered T Cells Market Size & Forecast (2019-2030)
6.2.6 China Engineered T Cells Market Size & Forecast (2019-2030)
6.2.7 Japan Engineered T Cells Market Size & Forecast (2019-2030)
6.2.8 Korea Engineered T Cells Market Size & Forecast (2019-2030)
6.2.9 Southeast Asia Engineered T Cells Market Size & Forecast (2019-2030)
6.2.10 India Engineered T Cells Market Size & Forecast (2019-2030)
6.2.11 South America Engineered T Cells Market Size & Forecast (2019-2030)
6.2.12 Middle East & Africa Engineered T Cells Market Size & Forecast (2019-2030)
7 North America
7.1 North America Engineered T Cells Revenue by Players
7.2 North America Engineered T Cells Revenue by Types
7.3 North America Engineered T Cells Revenue by Applications
7.4 North America Engineered T Cells Revenue, Gross and Gross Margin (2019-2024)
7.5 North America PEST Analysis
8 Europe
8.1 Europe Engineered T Cells Revenue by Players
8.2 Europe Engineered T Cells Revenue by Types
8.3 Europe Engineered T Cells Revenue by Applications
8.4 Europe Engineered T Cells Revenue, Gross and Gross Margin (2019-2024)
8.5 Europe PEST Analysis
9 China
9.1 China Engineered T Cells Revenue by Players
9.2 China Engineered T Cells Revenue by Types
9.3 China Engineered T Cells Revenue by Applications
9.4 China Engineered T Cells Revenue, Gross and Gross Margin (2019-2024)
9.5 China PEST Analysis
10 Japan
10.1 Japan Engineered T Cells Revenue by Players
10.2 Japan Engineered T Cells Revenue by Types
10.3 Japan Engineered T Cells Revenue by Applications
10.4 Japan Engineered T Cells Revenue, Gross and Gross Margin (2019-2024)
10.5 Japan PEST Analysis
11 Korea
11.1 Korea Engineered T Cells Revenue by Players
11.2 Korea Engineered T Cells Revenue by Types
11.3 Korea Engineered T Cells Revenue by Applications
11.4 Korea Engineered T Cells Revenue, Gross and Gross Margin (2019-2024)
11.5 Korea PEST Analysis
12 Southeast Asia
12.1 Southeast Asia Engineered T Cells Revenue by Players
12.2 Southeast Asia Engineered T Cells Revenue by Types
12.3 Southeast Asia Engineered T Cells Revenue by Applications
12.4 Southeast Asia Engineered T Cells Revenue, Gross and Gross Margin (2019-2024)
12.5 Southeast Asia PEST Analysis
13 India
13.1 India Engineered T Cells Revenue by Players
13.2 India Engineered T Cells Revenue by Types
13.3 India Engineered T Cells Revenue by Applications
13.4 India Engineered T Cells Revenue, Gross and Gross Margin (2019-2024)
13.5 India PEST Analysis
14 South America
14.1 South America Engineered T Cells Revenue by Players
14.2 South America Engineered T Cells Revenue by Types
14.3 South America Engineered T Cells Revenue by Applications
14.4 South America Engineered T Cells Revenue, Gross and Gross Margin (2019-2024)
14.5 South America PEST Analysis
15 Middle East & Africa
15.1 Middle East & Africa Engineered T Cells Revenue by Players
15.2 Middle East & Africa Engineered T Cells Revenue by Types
15.3 Middle East & Africa Engineered T Cells Revenue by Applications
15.4 Middle East & Africa Engineered T Cells Revenue, Gross and Gross Margin (2019-2024)
15.5 Middle East & Africa PEST Analysis
16 Engineered T Cells Business Cost Analysis
16.1 Proportion of Business Cost Structure
16.1.1 Labor Cost
16.1.2 Operating Expenses
16.2 Engineered T Cells Industrial Chain Analysis
17 Engineered T Cells Industry Dynamic Analysis
17.1 Engineered T Cells Market Trends Analysis
17.2 Engineered T Cells Market Drivers Analysis
17.3 Engineered T Cells Market Challenges Analysis
17.4 Engineered T Cells Market Restraints Analysis
18 Research Findings and Conclusion